New treatments of diabetes: the beta-amylin agonists.

Lebovitz, H E

Lebovitz, H E.

Affiliation

Lebovitz HE; Health Science Center at Brooklyn, Endocrinology & Metabolism/Diabetes, State University of New York, 450 Clarkson Avenue, Brooklyn, NY 11203, USA. hlebovitz1@hotmail.com

Ann Endocrinol (Paris) ; 69(2): 147-50, 2008 Apr.

Article in En | MEDLINE | ID: mdl-18423421

Subject(s)

Amyloid/agonists; Amyloid/therapeutic use; Diabetes Mellitus/drug therapy; Hypoglycemic Agents/pharmacology; Hypoglycemic Agents/therapeutic use; Amyloid/deficiency; Amyloid/pharmacology; Amyloid/physiology; Animals; Diabetes Mellitus/physiopathology; Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 2/drug therapy; Eating/drug effects; Glucagon/metabolism; Humans; Insulin/therapeutic use; Islet Amyloid Polypeptide

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Amyloid / Hypoglycemic Agents Limits: Animals / Humans Language: En Journal: Ann Endocrinol (Paris) Year: 2008 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google